Lovastatin inhibits transforming growth factor-β1 expression in diabetic rat glomeruli and cultured rat mesangial cells

Journal of the American Society of Nephrology

Volumn 11, Issue 1, 2000, Pages 80-87

  Kim, Sung Il ^a   Han, Dong Cheol ^a   Lee, Hi Bahl ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; MEVALONIC ACID; MEVINOLIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME INHIBITION; GENE EXPRESSION; GLOMERULUS FILTRATION; GLUCOSE BLOOD LEVEL; KIDNEY MASS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; URINARY EXCRETION;

EID: 0343114434     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Mauer SM: Structural-functional relationships in diabetic nephropathy. Kidney Int 74: 1143-1155, 1984
2. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, Haverty TP: High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule. Am J Physiol 259: F704-F714, 1990
3. Ayo SH, Radink RA, Glass WF II, Garoni JA, Rampt ER, Appling DR, Kreisberg JI : Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260: F185-F191, 1991
4. Fukui M, Nakamura T, Egihara I, Shirato I, Tomino Y, Koide H: Extracellular matrix component gene expression and its modulation by insulin in diabetic rats. Diabetes 41: 1520-1527, 1992
5. Oh JH, Ha H, Yu MR, Lee HB: Sequential effects of high glucose on mesangial cell TGF-β1 and fibronectin synthesis. Kidney Int 54: 1872-1878, 1998
6. Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN: Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule. Kidney Int 41: 107-114, 1992
7. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson SS: Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 74: 991-1003, 1996
8. Sharma K, Ziyadeh FN: The emerging role of transforming growth factor-β in kidney diseases. Am J Physiol 35: F829-F842, 1994
9. Laiho M, Saksela O, Andreasen PA, Keski-Oja J: Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β. J Cell Biol 103: 2403-2410, 1986
10. Border WA, Noble NA: Evidence that TGF-β should be a therapeutic target in diabetic nephropathy [Editorial]. Kidney Int 54: 1390-1391, 1998
11. Kasiske BL, O'Donnell MP, Garvis WJ, Keane WF: Pharmacologic treatment of hyperlipidemia reduces glomerular injury in the rat 5/6 nephrectomy model of chronic renal failure. Circ Res 62: 367-374, 1988
12. Lee SK, Jin SY, Han DC, Hwang SD, Lee HB: Effects of delayed treatment with enalapril and/or lovastatin on the progression of glomerulosclerosis in 5/6 nephrectomized rats. Nephrol Dial Transplant 8: 1338-1343, 1993
13. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33: 667-672, 1988
14. Han DC, Lee SK, Hwang SD, Lee HB: Lovastatin prevents glomerulosclerosis in streptozotocin-induced diabetic uninephrectomized rats [Abstract]. Kidney Int 44: 1181, 1993
15. O'Donnell MP, Kasiske BL, Kim Y, Atluru D. Keane WF: Lovastatin inhibits proliferation of rat mesangial cells. J Clin Invest 91: 83-87, 1993
16. Ghosh PM, Mott GE, Ghosh-Choudhury N. Radnik RA, Stapleton ML, Ghidoni JJ, Kreisgerg JI: Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells. Biochim Biophys Acta 1359: 13-24, 1997
17. Guijarro C, Kim Y, Schoonover CM, Massy ZA, O'Donnell MP, Kasiske BL, Keane WF, Kashtan CE: Lovastatin inhibits lipopolysaccharide-induced NF-kappa B activation in human mesangial cells. Nephrol Dial Transplant 11: 990-996, 1996
18. Guijarro C, Keane WF: Effects of lipids on the pathogenesis of progressive renal failure: Role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the prevention of glomerulosclerosis. Miner Electrolyte Metab 22: 147-152, 1996
19. Essig M, Vrtovsnik F, Nguyen G, Sraer JD, Friedlander G: Lovastatin modulates in vivo and in vitro the plasminogen activator/ plasmin system of rat proximal tubular cells: Role of geranylgeranylation and Rho proteins. J Am Soc Nephrol 9: 1377-1388, 1998
20. Han DC, Kim JH, Cha MK, Song KI, Hwang SD, Lee HB: Effect of HMG Co A reductase inhibition on TGF-β1 mRNA expression in diabetic rat glomeruli. Kidney Int 48[Suppl 51]: S61-S65, 1995
21. Weibel ER: Practical methods for biological morphometry. In: Stereological Methods, London, Academic Press, 1979, pp 44-45
22. Lee HB, Cha MK, Song KI, Kim JH, Lee EY, Kim SI, Kim J, Yoo MH: Pathogenic role of advanced glycosylation end products in diabetic nephropathy. Kidney Int 52[Suppl 60]: S60-S65, 1997
23. Lane PH, Steffes MW, Mauer SM: Estimation of glomerular volume: A comparison of four methods. Kidney Int 41: 1085-1089, 1992
24. Harper PA, Robinson JM, Hoover RL, Wright TC, Karnovsky MJ: Improved methods for culturing rat glomerular cells. Kidney Int 26: 875-880, 1984
25. Jakobisiak M, Bruno S, Skierski JS, Darzynkiewicz Z: Cell cycle-specific effects of lovastatin. Proc Natl Acad Sci USA 88: 3628-3632, 1991
26. Guijarro C, O'Donnell MP, Kasiske BL, Kim Y, Atluru D, Keane WF: Differential effects of lovastatin on human mesangial cell mRNA for cytokines involved in proliferation and matrix turnover [Abstract]. J Am Soc Nephrol 4: 770, 1993
27. Barr E, Leiden JM: Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254: 1507-1509, 1991
28. Madisen L, Lioubin MN, Farrand AL, Brunner AM, Purchio AF: Analysis of proteolytic cleavage of recombinant TGF-β1: Production of hybrid molecules with increased processing efficiency. Ann NY Acad Sci 593: 7-25, 1990
29. Casey PJ: Protein lipidation in cell signaling. Science 268: 221-225, 1995
30. Kim SI, Lee HB: Effect of lovastatin on mesangial cell synthesis of TGF-β1 and fibronectin [Abstract]. J Am Soc Nephrol 9: 635A, 1998
31. Kim S-J, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, Karin M, Robers AB: Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol Cell Biol 10: 1492-1497, 1990
32. Zhang Y, Feng XH, Deryneck R: Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 394: 909-913, 1998
33. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator. Diabetes 44: 1139-1146, 1995